EG20191A - Novel 3,3'- dithobis (propionic acids) and esters thereof - Google Patents
Novel 3,3'- dithobis (propionic acids) and esters thereofInfo
- Publication number
- EG20191A EG20191A EG38991A EG38991A EG20191A EG 20191 A EG20191 A EG 20191A EG 38991 A EG38991 A EG 38991A EG 38991 A EG38991 A EG 38991A EG 20191 A EG20191 A EG 20191A
- Authority
- EG
- Egypt
- Prior art keywords
- esters
- dithobis
- novel
- propionic acids
- propionic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002274A SE9002274D0 (sv) | 1990-06-28 | 1990-06-28 | Novel 3,3'-dithiobis(propionic esters). |
SE9002275A SE9002275D0 (sv) | 1990-06-28 | 1990-06-28 | Novel 3,3'-dithiobis(propionic acids) |
Publications (1)
Publication Number | Publication Date |
---|---|
EG20191A true EG20191A (en) | 1997-09-30 |
Family
ID=26660808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG38991A EG20191A (en) | 1990-06-28 | 1991-06-20 | Novel 3,3'- dithobis (propionic acids) and esters thereof |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0463514B1 (et) |
JP (1) | JPH04230359A (et) |
KR (1) | KR920000714A (et) |
CN (1) | CN1039318C (et) |
AT (1) | ATE120730T1 (et) |
AU (1) | AU642259B2 (et) |
CA (1) | CA2045289A1 (et) |
CZ (1) | CZ279343B6 (et) |
DE (1) | DE69108616T2 (et) |
DK (1) | DK0463514T3 (et) |
EG (1) | EG20191A (et) |
ES (1) | ES2070370T3 (et) |
FI (1) | FI913131A (et) |
HK (1) | HK62397A (et) |
HR (1) | HRP920766A2 (et) |
HU (1) | HU210675B (et) |
IE (1) | IE71024B1 (et) |
IL (1) | IL98389A (et) |
IS (1) | IS1697B (et) |
JO (1) | JO1677B1 (et) |
LV (1) | LV10231B (et) |
NO (1) | NO175307C (et) |
NZ (1) | NZ238495A (et) |
PH (1) | PH30951A (et) |
PL (2) | PL165344B1 (et) |
PT (1) | PT98121B (et) |
RU (1) | RU2041208C1 (et) |
SI (1) | SI9111086A (et) |
SK (1) | SK278710B6 (et) |
TW (1) | TW221376B (et) |
YU (1) | YU48643B (et) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103572D0 (sv) * | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
SE9500897D0 (sv) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cystine derivatives |
KR20010075000A (ko) * | 1998-10-09 | 2001-08-09 | 에가시라 구니오 | 시스테인 유도체 |
SE9900438D0 (sv) * | 1999-02-10 | 1999-02-10 | Astra Ab | The pharmacological use of certian cystine derivatives |
US8295265B2 (en) | 2005-11-16 | 2012-10-23 | Htc Corporation | Method for handling radio bearer messages during reset and reestablishment in a wireless system |
US7829709B1 (en) | 2007-08-10 | 2010-11-09 | Marquette University | Cysteine prodrugs to treat schizophrenia and drug addiction |
US8173809B2 (en) | 2008-02-07 | 2012-05-08 | Marquette University | Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
CN103319388B (zh) * | 2013-06-08 | 2014-11-05 | 西安交通大学 | 一种双功能聚乙二醇衍生物及其制备方法 |
CN106232577B (zh) * | 2014-04-25 | 2019-02-22 | 味之素株式会社 | 免疫刺激剂 |
JP2018536645A (ja) | 2015-10-28 | 2018-12-13 | 味の素株式会社 | 免疫賦活剤 |
EP3395365A1 (en) | 2017-04-28 | 2018-10-31 | Ajinomoto Co., Inc. | Immunostimulating agent |
CN111072537B (zh) * | 2019-12-20 | 2021-11-19 | 南京德尔诺医药科技有限公司 | 一种双乙酰化-l-胱氨酸的制备方法及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR8205M (et) * | 1968-12-20 | 1970-09-14 | ||
US3878305A (en) * | 1972-05-25 | 1975-04-15 | Procter & Gamble | Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids |
US3952115A (en) * | 1975-04-02 | 1976-04-20 | The Procter & Gamble Company | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters |
FR2503151A1 (fr) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux |
US4827016A (en) * | 1985-09-16 | 1989-05-02 | Morgan Lee R | Method and compounds for reducing dermal inflammations |
US4708965A (en) * | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
JPS62195356A (ja) * | 1986-02-20 | 1987-08-28 | Seiwa Kasei:Kk | シスチン誘導体及びその塩 |
-
1991
- 1991-05-28 TW TW080104179A patent/TW221376B/zh active
- 1991-06-05 IL IL98389A patent/IL98389A/xx not_active IP Right Cessation
- 1991-06-11 NZ NZ238495A patent/NZ238495A/en not_active IP Right Cessation
- 1991-06-11 AU AU78284/91A patent/AU642259B2/en not_active Ceased
- 1991-06-14 AT AT91109808T patent/ATE120730T1/de not_active IP Right Cessation
- 1991-06-14 DK DK91109808.5T patent/DK0463514T3/da active
- 1991-06-14 DE DE69108616T patent/DE69108616T2/de not_active Expired - Fee Related
- 1991-06-14 ES ES91109808T patent/ES2070370T3/es not_active Expired - Lifetime
- 1991-06-14 EP EP91109808A patent/EP0463514B1/en not_active Expired - Lifetime
- 1991-06-19 SI SI9111086A patent/SI9111086A/sl unknown
- 1991-06-19 YU YU108691A patent/YU48643B/sh unknown
- 1991-06-20 EG EG38991A patent/EG20191A/xx active
- 1991-06-24 CA CA002045289A patent/CA2045289A1/en not_active Abandoned
- 1991-06-25 PH PH42684A patent/PH30951A/en unknown
- 1991-06-26 IE IE222391A patent/IE71024B1/en not_active IP Right Cessation
- 1991-06-27 PT PT98121A patent/PT98121B/pt active IP Right Grant
- 1991-06-27 JP JP3181592A patent/JPH04230359A/ja active Pending
- 1991-06-27 KR KR1019910010793A patent/KR920000714A/ko not_active Application Discontinuation
- 1991-06-27 NO NO912545A patent/NO175307C/no not_active IP Right Cessation
- 1991-06-27 JO JO19911677A patent/JO1677B1/en active
- 1991-06-27 FI FI913131A patent/FI913131A/fi unknown
- 1991-06-27 HU HU912169A patent/HU210675B/hu not_active IP Right Cessation
- 1991-06-27 RU SU914895759A patent/RU2041208C1/ru not_active IP Right Cessation
- 1991-06-28 SK SK1990-91A patent/SK278710B6/sk unknown
- 1991-06-28 PL PL91290857A patent/PL165344B1/pl not_active IP Right Cessation
- 1991-06-28 CZ CS911990A patent/CZ279343B6/cs unknown
- 1991-06-28 CN CN91104324A patent/CN1039318C/zh not_active Expired - Fee Related
- 1991-06-28 IS IS3728A patent/IS1697B/is unknown
- 1991-06-28 PL PL91293118A patent/PL165349B1/pl not_active IP Right Cessation
-
1992
- 1992-10-01 HR HRP-1086/91A patent/HRP920766A2/xx not_active Application Discontinuation
-
1993
- 1993-06-30 LV LVP-93-822A patent/LV10231B/en unknown
-
1997
- 1997-05-08 HK HK62397A patent/HK62397A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK14294A (en) | Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid | |
EG20191A (en) | Novel 3,3'- dithobis (propionic acids) and esters thereof | |
HUT59600A (en) | Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases | |
AU5490690A (en) | Process for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
IE881710L (en) | (2-Cyano-2-oximinoacetyl)-amino acid derivatives | |
GR900300167T1 (en) | Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it | |
GR3007585T3 (et) | ||
IL105229A0 (en) | The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and esters as medicaments | |
EP0418990A3 (en) | 13-bromo and 13,14-dibromo ergoline, their preparation and their use | |
HUT44802A (en) | Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them | |
LTIP1739A (en) | Novel 3,3'-dithiobis(propionic acids) and esthers thereof, process for their preparation and pharmaceutical preparation | |
IL86752A (en) | Thiophene derivatives and their preparation and their use as intermediates in the preparation of n-(2,4-dimethylthien-3-yl) -n-(1-methoxyprop-2-yl) - chloroacetamide | |
GR3004354T3 (et) | ||
HUT71485A (en) | N-alkylized esters of 1,4-dihydropyridine-carboxylic acids, process for producing them, and pharmaceutical compositions containing them |